Oscar Health, Inc. OSCR
We take great care to ensure that the data presented and summarized in this overview for Oscar Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OSCR
View all-
Vanguard Group Inc Valley Forge, PA14.6MShares$300 Million0.0% of portfolio
-
Dragoneer Investment Group, LLC San Francisco, CA12.7MShares$262 Million4.84% of portfolio
-
Black Rock Inc. New York, NY12.2MShares$251 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.37MShares$193 Million2.88% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.54MShares$176 Million0.08% of portfolio
-
Thrive Capital Management, LLC New York, NY4.76MShares$97.8 Million10.03% of portfolio
-
Viking Global Investors LP4.73MShares$97.3 Million0.27% of portfolio
-
State Street Corp Boston, MA4.65MShares$95.7 Million0.0% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY4.22MShares$86.8 Million0.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.98MShares$81.8 Million0.01% of portfolio
Latest Institutional Activity in OSCR
Top Purchases
Top Sells
About OSCR
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Insider Transactions at OSCR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 03
2024
|
Mark T Bertolini Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
955,555
+50.0%
|
-
|
Mar 06
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
13,233
-5.85%
|
$185,262
$14.12 P/Share
|
Mar 06
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,043
-4.22%
|
$378,602
$14.12 P/Share
|
Mar 05
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+12.14%
|
-
|
Mar 05
2024
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+8.88%
|
-
|
Mar 04
2024
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
33,707
-22.2%
|
$505,605
$15.88 P/Share
|
Mar 04
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
15,928
-7.56%
|
$238,920
$15.88 P/Share
|
Mar 04
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,346
-2.42%
|
$215,190
$15.88 P/Share
|
Mar 04
2024
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,426
-9.16%
|
$171,390
$15.88 P/Share
|
Mar 01
2024
|
Victoria Baltrus Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,643
+33.26%
|
-
|
Mar 01
2024
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,432
+7.19%
|
-
|
Mar 01
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,395
+8.92%
|
-
|
Mar 01
2024
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,592
+3.6%
|
-
|
Mar 01
2024
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,872
+13.76%
|
-
|
Feb 16
2024
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
42,865
-32.8%
|
$771,570
$18.03 P/Share
|
Feb 16
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
55,000
-24.51%
|
$990,000
$18.02 P/Share
|
Dec 06
2023
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,029
-5.19%
|
$240,232
$8.16 P/Share
|
Dec 06
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
16,793
-5.28%
|
$134,344
$8.16 P/Share
|
Dec 05
2023
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+9.75%
|
-
|
Dec 05
2023
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+8.95%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 2.34M shares |
---|---|
Grant, award, or other acquisition | 194K shares |
Conversion of derivative security | 625K shares |
Open market or private sale | 7.92M shares |
---|